| Application no. and date | 18786587.8 (espacenet) (Federated) (European Patent Register), 20180926 | | Patent/reg. no. and date | DK/EP 3687562, 20250319 | | Publication date | 20200805 | | Priority no. and date | US 201762563387 P, 20170926, US 201862616819 P, 20180112, US 201862625075 P, 20180201, US 201862639425 P, 20180306, US 201862654291 P, 20180406, US 201862691552 P, 20180628, US 201862716331 P, 20180808 | | EP pub. no. and date |
EP 3687562 20200805 | | Effective date | | | Applicant/owner | Regeneron Pharmaceuticals, Inc., 777 Old Saw Mill River Road
Tarrytown, NY 10591, US | | Applicant ref. no. | V2503-016-DK | | Inventor | TESSARI, Eben, 100 Hayden Avenue
Lexington
MA 02421, US,
PAOLINI, John, 100 Hayden Avenue
Lexington
MA 02421, US | | Representative | NORDIC PATENT SERVICE A/S, Bredgade 30, 1260 København K | | Opponent | | | IPC Class | A61K 38/17 (2006.01) , A61K 38/20 (2006.01) , A61K 39/395 (2006.01) , A61K 47/68 (2017.01) , A61P 29/00 (2006.01) , A61P 9/00 (2006.01) | | Title | BEHANDLING AF TILBAGEVENDENDE IDIOPATISK PERICARDITIS VED INDGIVELSE AF INTERLEUKIN-1-RECEPTORANTAGONIST-FUSIONSPROTEIN | | Int. application no. | US2018052985 | | Int. publication no. | WO2019067639 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
